Company intelligence / Profile preview

Manina Medtech

Barcelona, Catalonia/Catalunya, Spainmaninamedtech.com ↗

Ownership: Private
Employees: ~10
Development stage: Preclinical

Overview

Manina Medtech has developed SEEDCHRONY, a non-invasive, AI-powered medical device that assesses uterine readiness for embryo transfer by analyzing biomarkers in uterine fluid. The device provides immediate results on the day of IVF embryo transfer, aiming to increase pregnancy rates by up to 30%. Initial clinical trials have shown satisfactory results; further patient studies and regulatory validation are ongoing[1][4][5][6].

Therapeutic areas: Women's Health
Modalities: DeviceAI-based diagnostic tool (for endometrial receptivity)
Industry: Digital Health Medical Devices

Partnerships

Vall d’Hebron University Hospital Gynecological Endocrinology and Assisted Reproduction Unit (clinical collaboration)

Beyond the preview

Go deeper on Manina Medtech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Manina Medtech.

Explore the full profile